A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label study to evaluate the safety and efficacy of treatment with
brentuximab vedotin (SGN-35) in patients who have previously participated in an brentuximab
vedotin study.